STERIS plc (Ireland) – Consensus shows a potential upside of 14.9%

by admin
STERIS plc (Ireland) – Consensus shows a potential upside of 14.9%
STERIS plc (Ireland) – Consensus shows a potential upside of 14.9%

[ad_1]

STERIS plc (Ireland) with ticker code (STE) now has 5 analysts covering the stock with a consensus offering a Buy rating. The range between the high price target and the low price target is between 250 and 190 with an average TP of 221. Now with the previous close price of 192.31 this shows that there is a potential upside of 14.9%. It has a 50-day moving average of 170.55, while the 200-day moving average is 207.7. The company has a market cap of $19.157 million. Visit the company’s website at: https://www.steris.com

The potential market cap would be $22,015 million based on market consensus.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to see it.

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. The Healthcare segment offers cleaning chemicals and sterility products; an automated system for reprocessing endoscopes and tracking products; gastrointestinal (GI) procedure accessories, washers, sterilizers and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights and connectivity solutions, and equipment management services. It also provides installation, maintenance, upgrade, repair and troubleshooting services for major equipment; Preventive maintenance programs and repair services; Repair and maintenance of instruments and endoscopes; and custom process improvement consulting and outsourced sterile instrument processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services to medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumables such as formulated cleaning chemicals, barrier and sterility products, steam and vaporized hydrogen peroxide sterilizers and laundry sanitizers. This segment also offers equipment installation, maintenance, upgrade, repair and troubleshooting services; and preventive maintenance programs and repair services. The dental segment offers hand and powered dental instruments, infection control products, personal protective equipment and water quality products for the dental suite. The company serves its products and services to hospitals, other healthcare providers and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

[ad_2]

Source link

You may also like